Telithromycin (Ketek) for respiratory tract infections

American Family Physician

Volumn 70, Issue 6, 2004, Pages 1121-1122

  Steadman, M Sharm ^a   Sutton, S Scott ^a,b  

^a UNIVERSITY OF SOUTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; ASPARTATE AMINOTRANSFERASE; AZITHROMYCIN; CEFUROXIME AXETIL; CLARITHROMYCIN; CYTOCHROME P450 3A4; DIGOXIN; KETOLIDE; MIDAZOLAM; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SIMVASTATIN; TELITHROMYCIN; TROVAFLOXACIN;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BACTERIAL INFECTION; CHRONIC BRONCHITIS; COMMUNITY ACQUIRED PNEUMONIA; DIARRHEA; DISEASE EXACERBATION; DRUG COST; DRUG EFFICACY; DRUG INDICATION; DRUG METABOLISM; DRUG SAFETY; DRUG TOLERABILITY; HUMAN; LIVER TOXICITY; NAUSEA AND VOMITING; NONHUMAN; QT PROLONGATION; RESPIRATORY TRACT INFECTION; SHORT SURVEY; SINUSITIS; STREPTOCOCCUS PNEUMONIAE;

EID: 4644254077     PISSN: 0002838X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (4)

1. Shain CS, Amsden GW. Telithromycin: the first of the ketolides. Ann Pharmacother 2002;36:452-64.
2. Zhanel GG, Walters M, Noreddin A, Vercaigne LM, Wierzbowski A, Embil JM, et al. The ketolides: a critical review. Drugs 2002;62:1771-804.
3. Aventis Pharma. Ketek (telithromycin package insert. 2003. Accessed online August 24, 2004, at: http:// www.aventis-us.com/Pls/ketek.pdf.
4. Fogarty CM, Kohno S, Buchanan P, Aubier M, Baz M. Comunity-acquired respiratory tract infections caused by resistant pneumococci: clinical and bacteriological efficacy of the ketolide telithromycin. J Antimocrob Chemotherapy 2003;51:947-55.